EGFR and non-small cell lung carcinoma: We found that patients with higher TAM abundance (as indicated by enrichment score of TAM signature) are associated with worse overall survival, and interestingly, this association is more significant in patients with EGFR-mutant NSCLC (Figure 3E, Supplementary Figures 3C, D).